Farzan Nima bought KROS
June 3, 2026 · Form 4 insider transaction
Farzan Nima bought 7,433 shares of Keros Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,433
Price
$0.00
Total value
N/A
InsiderFarzan Nima
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 3, 2026
Filing dateJune 5, 2026
Shares owned after7,433
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option shall vest in equal quarterly installments over the 12 months following June 3, 2026, provided that the grant will in any case be fully vested on the date of Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date.